Literature DB >> 15786720

Increased expression of IL-6 and LIF in the hypertrophied left ventricle of TGR(mRen2)27 and SHR rats.

Mazen Kurdi1, Jacques Randon, Catherine Cerutti, Giampiero Bricca.   

Abstract

Cytokines from the interleukin-6 (IL-6) family have been reported to play an important synergistic role with angiotensin II in the development of pathological cardiac hypertrophy. Whether their expression pattern changes in vivo, in an angiotensin I-dependent hypertrophied myocardium has not been reported. In this study, we addressed that issue using two animal models of angiotensin II-dependent cardiac hypertrophy. Heterozygous transgenic TGR(mRen2)27 (TGR) with an overactive cardiac renin angiotensin system and the closely related spontaneously hypertensive rats (SHR) were compared to their respective control rats. The mRNA levels of IL-6, leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF) and cardiotrophin-1 (CT-1) as well as their receptor subunits, glycoprotein 130 (gp130), IL-6 receptor (IL-6R), LIFR, and CNTFR, were measured by semi-quantitative RT-PCR. The protein levels of IL-6, LIF and CT-1 were investigated by western blot. TGR and SHR both displayed significant over expression of mRNA and protein levels for IL-6 and LIF. In TGR, the increased level of LIF was accompanied by a decrease in mRNA levels for LIFR and CNTFR. In SHR, a higher level of mRNA IL-6R was observed. By contrast, the mRNA and protein levels for CT-1 and the mRNA level for gp130 did not vary in these two models. These findings suggest that IL-6 and LIF, but not CT-1, contribute to angiotensin II-dependent left ventricular hypertrophy in the two hypertensive rat models, TGR(mRen2)27 and SHR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786720     DOI: 10.1007/s11010-005-3085-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.

Authors:  E Tone; K Kunisada; A Kumanogoh; S Negoro; M Funamoto; T Osugi; T Kishimoto; K Yamauchi-Takihara
Journal:  Cytokine       Date:  2000-10       Impact factor: 3.861

2.  Role of angiotensin-converting enzyme, adrenergic receptors, and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development.

Authors:  K Ohta; S Kim; H Iwao
Journal:  Hypertension       Date:  1996-10       Impact factor: 10.190

3.  Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart.

Authors:  F Wang; Y Seta; G Baumgarten; D J Engel; N Sivasubramanian; D L Mann
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

4.  Different expression of renin-angiotensin system components in hearts of normotensive and hypertensive rats.

Authors:  D Jurkovicová; Z Dobesová; J Kunes; O Krizanová
Journal:  Physiol Res       Date:  2001       Impact factor: 1.881

5.  Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3 : an autocrine loop for hypertrophy.

Authors:  J Fukuzawa; G W Booz; R A Hunt; N Shimizu; V Karoor; K M Baker; D E Dostal
Journal:  Hypertension       Date:  2000-06       Impact factor: 10.190

6.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Increased expression of cardiotrophin-1 during ventricular remodeling in hypertensive rats.

Authors:  Yoshihito Takimoto; Takeshi Aoyama; Yoshitaka Iwanaga; Toshiaki Izumi; Yasuki Kihara; Diane Pennica; Shigetake Sasayama
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-03       Impact factor: 4.733

Review 8.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

9.  Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.

Authors:  K Mizuno; M Tani; S Hashimoto; S Niimura; H Sanada; H Watanabe; M Ohtsuki; S Fukuchi
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

10.  [Expression of cytokines and their receptors in left ventricular hypertrophy in TGR(mRen2)27 rats].

Authors:  M Kurdi; N Dizerens; C Cerutti; G Bricca; J Randon
Journal:  Arch Mal Coeur Vaiss       Date:  2003 Jul-Aug
View more
  15 in total

1.  Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.

Authors:  Pearl Quijada; Haruhiro Toko; Kimberlee M Fischer; Brandi Bailey; Patrick Reilly; Kristin D Hunt; Natalie A Gude; Daniele Avitabile; Mark A Sussman
Journal:  Circ Res       Date:  2012-05-22       Impact factor: 17.367

2.  Biomarkers of inflammation and hemostasis associated with left ventricular mass: The Multiethnic Study of Atherosclerosis (MESA).

Authors:  Donna K Arnett; Robyn L McClelland; Alan Bank; David A Bluemke; Mary Cushman; Alexander J Szalai; Nishank Jain; Antoinette S Gomes; Susan R Heckbert; W Gregory Hundley; João A Lima
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-28

Review 3.  Cardiotrophin-1 in hypertensive heart disease.

Authors:  Arantxa González; Begoña López; Susana Ravassa; Javier Beaumont; Amaia Zudaire; Idoia Gallego; Cristina Brugnolaro; Javier Díez
Journal:  Endocrine       Date:  2012-03-15       Impact factor: 3.633

Review 4.  TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection.

Authors:  Adam J Booth; D Keith Bishop
Journal:  Immunotherapy       Date:  2010-07       Impact factor: 4.196

5.  Involvement of ERCC1 in the pathogenesis of osteoarthritis through the modulation of apoptosis and cellular senescence.

Authors:  Koji Takayama; Yohei Kawakami; Sahnghoon Lee; Nick Greco; Mitra Lavasani; Yutaka Mifune; James H Cummins; Takashi Yurube; Ryosuke Kuroda; Masahiro Kurosaka; Freddie H Fu; Johnny Huard
Journal:  J Orthop Res       Date:  2014-06-25       Impact factor: 3.494

6.  Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection.

Authors:  J A Diaz; A J Booth; G Lu; S C Wood; D J Pinsky; D K Bishop
Journal:  Am J Transplant       Date:  2009-06-16       Impact factor: 8.086

Review 7.  Mechanisms and consequences of inflammatory signaling in the myocardium.

Authors:  Jihyun Ahn; Jaetaek Kim
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 8.  STAT transcription in the ischemic heart.

Authors:  Richard A Knight; Tiziano M Scarabelli; Anastasis Stephanou
Journal:  JAKSTAT       Date:  2012-04-01

9.  Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction.

Authors:  Tian-Meng Chen; Jian Li; Lin Liu; Li Fan; Xiao-Ying Li; Yu-Tang Wang; Nader G Abraham; Jian Cao
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

10.  Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo.

Authors:  Barbara Coles; Ceri A Fielding; Stefan Rose-John; Jürgen Scheller; Simon A Jones; Valerie B O'Donnell
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.